Tempest Therapeutics plans in vivo CAR-T trial for late 2026
Go back to Tempest Therapeutics plans in vivo CAR-T trial for late 2026| Tempest Trading Technologies, Inc. (NASDAQ: TPST) | Delayed: 0.99 -0.04 (3.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $0.01 | |||
| Open | $1.02 | 52 Week Low | $0.00 | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $0.98 | EPS | $0.00 | |||
| Volume | 199,940 | |||||
